GENEMATRIX
WVB Number : KOR000040597 | Country : Republic of Korea |
SIC categorization : COML PHYSICAL, BIOLOGCL RESH (8731) | ISIN : KR7109820001 |
FT categorization : DIV'D HEALTH & PERSONAL CARE (430) | |
Company status: ACTIVE |
» Corporation Profile :
Profile in brief: The Company is a Korea-based biotechnology company. The Company mainly develops restriction fragment mass polymorphisms (RFMP) clinical diagnostic systems, RFMP molecular markers, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) theranostics systems, molecular diagnostic platforms, and systems for microorganism identification. |
|
Phone : 82 031 628 2000 | Fax : 031 628 2002 |
Chairman: : N/A | Auditor : SAMIL PRICEWATERHOUSE COOPERS |
CEO/Managing Director : WANG DON YOO |
» Company Facts
Net Profit Margin (%) | -28.32 |
Operating Margin (%) | -31.55 |
Return on Assets (%) | -7.93 |
Return on Equity (%) | -11.51 |
Employees | 15 |
» Company Financials
Annual (2017) | |
Income Statement ('000 KRW ) |
|
Sales/Total Revenue | 5,189,163 |
EBITDA | -1,431,650 |
EBIT | -1,762,136 |
Net Income | -1,469,764 |
Balance Sheet ( '000 KRW) |
|
Total Current Assets | 11,080,946 |
Total Assets | 17,743,477 |
Current Liabilities | 5,025,483 |
Total Liabilities & Debt | 5,798,348 |
Total Equity | 11,945,129 |
Cash & Flow ( '000 KRW) |
|
Net Income/Staring Line | -1,734,513 |
Cash from Operating | -1,773,701 |
Cash from Investing | 1,726,614 |
Cash from Financing | 90,879 |
Cash & Equivalent Yr End | 1,262,785 |